Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-01

FDA Approved: CARBAMAZEPINE — Supplemental Application (Bionpharma Inc.,)

View source ↗

Summary

FDA approved a supplemental application for carbamazepine from Bionpharma Inc. This action confirms regulatory clearance for the product under the generic drug …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

SUPPL AP for CARBAMAZEPINE (CARBAMAZEPINE)